塩酸アセブトロールの多形
スポンサーリンク
概要
- 論文の詳細を見る
Acebutolol hydrochloride was proved by thermal analysis (DTA and TG), IR spectra, and X-ray powder diffraction to have three crystalline forms (form I, II, and III) and an amorphous form. The amorphous form, which was stored at 20°under 91% R.H., was first transformed to forms II and III, and then it was finally transformed to form I. During this transformation, the incorporation and release of water were examined. Form I was stable at this condition, while form II was transformed to form I for 48 hr, and form III was transformed to form I for 2 hr. Further, it was found that the amorphous form was transformed to form II at 80°under 50% R.H. for 3 hr, but at 80°under vacuum it was transformed to form III. Form I at 138°for 8 hr and form III at 130°for 4 hr were transformed to form II. From these results it was concluded that form I was the most stable form at room temperature.
- 公益社団法人日本薬学会の論文
- 1979-02-25
著者
-
杉本 功
(present Address)department Of Pharmacy Kitano Hpspital
-
杉本 功
鐘紡(株)・薬品研究所
-
粟田 則男
Department Of Formulation Research Pharmaceuticals Research Center Kanebo Ltd.
-
粟田 則男
Product Research And Development Laboratories Pharmaceuticals Research Center Kanebo Ltd.
-
山本 惠一
カネボウ(株)漢方ヘルスケア研究所
-
山本 恵一
Pharmaceutical Research Center Kanebo Ltd.
-
坂田 英彦
基礎研究所
-
佐藤 久
日本ローディア(株)
-
中川 寛
Pharmaceuticals Research Center Kanebo Ltd.
-
中川 寛
鐘紡(株)薬品研究所
-
中川 寛
鐘紡
関連論文
- A Widely Applicable Electrode Sensitive to Basic Drugs Based on Poly(vinyl chloride) Membrane Plasticized with Tricresyl Phosphate
- Supersaturation Mechanism of Drugs from Solid Dispersions with Enteric Coating Agents
- Application of Solid Dispersions with Enteric Coating Agents to Overcome some Pharmaceutical Problems
- Physical Properties of Solid Dispersions of Poorly Water-Soluble Drugs with Enteric Coating Agents
- 腸溶性ニフェジピン固体分散体の溶解機構について
- Application of Solid Dispersions of Nifedipine with Enteric Coating Agent to Prepare a Sustained-Release Dosage Form
- Bioavailability and Stability of Nifedipine-Enteric Coating Agent Solid Dispersion
- 圧縮過程におけるマイクロカプセル壁膜の破壊
- 吸湿によるヒドロキシプロピルセルロース含有錠の崩壊延長
- ニフェジピンと腸溶性コーティング剤から成る固体分散について(第1報)溶出挙動
- Identification of Nifedipine Metabolites and Their Determination by Gas Chromatography
- Effects of Grinding and Drying on the Solid-State Stability of Ampicillin Trihydrate
- The Effects of Grinding and Drying on the Solid State Stability of Sodium Prasterone Sulfate
- ニフェジビン錠の光分解におよぼす波長依存性
- The Properties of Water of Crystallization of Sodium Prasterone Sulfate
- カプセルからのリファンピシンの溶出におよぼす粒径とステアリン酸マグネシウムの影響
- 塩化ベルベリン錠の崩壊, 溶出におよぼす結晶水の影響
- 塩化ベルベリンの結晶水について
- Immunoaffinity Extraction of 4-Hydroxy-2-(4-methylphenyl) benzothiazole and Its Metabolites for Determination by Gas Chromatography-Mass Spectrometry
- 生薬「猪苓」標準化のための指標成分の探索
- 塩酸アセブトロールの多形
- Dehydroepiandrosterone Sulfate の家兎における吸収, 排泄および代謝
- 乙字湯エキス粉末のラット胎児器官形成期経口投与試験
- 加味帰脾湯エキス粉末のラット胎児器官形成期経口投与試験
- 加味帰脾湯エキス粉末のラットにおける3ヵ月間反復経口投与毒性試験
- 人参養栄湯エキス粉末のラットにおける3ヵ月間反復経口投与毒性試験
- 期待と反省(何を期待して年会に参加するか)
- A New Approach to Evaluating Photo-Stability of Nifedipine and Its Derivatives in Solution by Avtinometry
- 4-フルオロ-7-ニトロベンゾ-2-オキサ-1,3-ジアゾールをプレカラム誘導体化試薬に用いる高速液体クロマトグラフィーによる血しょう中フェニルプロパノールアミンの蛍光定量(医薬品の分析)
- Photo-Stability of Several Crystal Forms of Cianidanol
- シアニダノールの結晶形
- Degradation of (+)-Cyanidanol-3 by Sodium Sulfite in Aqueous Solution. II. Reactivity of Several (+)-Cyanidanol-3 Derivatives with Sodium Sulfite
- High-Performance Liquid Chromatographic Determination of Ferulic Acid in Plasma
- Absorption and Metabolism of γ-Oryzanol in Rats
- Degradation of (+)-Cyanidanol-3 by Sodium Sulfite in Aqueous Solution
- Stability and Bioavailability of Nifedipine in Fine Granules
- Mass Fragmentographic Determination of Ferulic Acid in Plasma after Oral Administration of γ-Oryzanol
- Stability of (+)-Cyanidanol-3 in Aqueous Solution
- Stability of Nifedipine-Polyvinylpyrrolidone Coprecipitate
- 家兎におけるγ-Oryzanolの代謝
- プラステロン硫酸の腟吸収性に及ぼす坐剤基剤の影響
- Transdermal Administration of Emedastine
- Wavelength Dependency and Mechanism of the Photo-Degradation of Ethyl 2-[4,5-Bis(4-methoxyphenyl)thiazole-2-yl]pyrrol-1-ylacetate (KBT-3022) in Solution
- Photo-Stability of the New Antiplatelet Agent, KBT-3022 (Ethyl 2-[4,5-Bis(4-methoxyphenyl)thiazole-2-yl]pyrrol-1-ylacetate) in Aqueous Solutions Containing Acetonitrile
- Determination of the Antiallergic Agent KB-2413 in Plasma by Means of Capillary Gas Chromatography with a Nitrogen-Sensitive Detector
- 錠剤内の粒子配列について(第3報)圧縮過程でのアスピリン結晶粒子の配列の変化
- 錠剤内の粒子配列について(第2報)アスピリン結晶形状の粒子配列および成形性におよぼす影響
- 錠剤内の粒子配列について(第1報)配列状態の測定法
- 抗酸化剤の研究 : (第4報)ω, ω′-Bis-p-aminophenol誘導体の合成ならびにその抗酸化性
- 塩酸ロメリジン(KB-2796)のラットにおける代謝
- Contributions of Various Serum Proteins to the Binding of Prasterone Sulfate in Humans
- Hepatic Transport of an Antiallergic Agent, Emedastine Difumarate : Interspecies Difference in Rats and Guinea Pigs
- 抗アレルギー薬フマル酸エメダスチンのラット及びモルモットにおけるin Vitro代謝
- 高速液体クロマトグラフィー/ラジオレセプターアッセイによるヒト血漿中の抗アレルギー薬, フマル酸エメダスチン(KG-2413), の選択的高感度定量
- 抗アレルギー薬1-(2-Ethoxyethyl)-2-(hexahydro-4-methyl-1H-1,4-diazepin-1-yl)-1H-benzimidazole Difumarate(KG-2413)のラジオレセプターアッセイにおける活性代謝物の交差性
- 抗アレルギー薬1-(2-Ethoxyethyl)-2-(hexahydro-4-methyl-1H-1,4-diazepin-1-yl)-1H-benzimidazole Difumarate(KG-2413)のラットにおける代謝物の同定
- Interspecies Differences in Pharmacokinetics of an Antiallergic Agent, 1-(2-Ethoxyethyl)-2-(hexahydro-4-methyl-1,4-diazepin-1-yl)benzimidazole Difumarate (KG-2413) after Intravenous Administration to Rats, Guinea Pigs and Dogs
- キャピラリ-GC/MSによるシアニダノ-ルの代謝研究 (GC/MS特集)
- Determination of the Antiplatelet Agent, KB-3022,and Its Metabolite by High-Performance Liquid Chromatography
- Physicochemical Characterization of Trazodone Hydrochloride Tetrahydrate
- ガスクロマトグラフ法による新規抗血小板薬KBT-3022の主代謝物(Desethyl KBT-3022)の血漿中微量定量
- 〔3-2H〕-および〔3-3H〕-シアニダノ-ルの合成
- Dehydroepiandrosterone Sulfateのin Vitro代謝(第1報)ヒトおよびサル妊娠末期胎盤における代謝
- 補中益気湯エキス粉末のラット胎児器官形成期経口投与試験
- Determination of Residual Solvents in Drug Substances by Gas Chromatography with Thermal Desorption Cold Trap Injection
- Determination of Sulfur in Pharmaceutical Preparations Using Reversed-Phase High-Performance Liquid Chromatography
- Flutoprazepam(KB-509)の生体内動態(第4報)イヌにおけるFlutoprazepam-2-^CおよびDesalkylflutoprazepam-2-^Cの血漿中動態
- Effects of Tableting Procedures on the Preferred Orientation of Crystalline Particles